Medicine, life sciences, pharmaceutical and biotechnology licences
Our technologies are available for licensing to innovative organisations seeking to develop their current activities or diversify their operations. We have many licences available at any time, here is a sample of some of our most exciting innovations.
Our licences cover the spectrum of medicine, life sciences, pharmaceutical and biotechnology, so please contact us to find out about other opportunities or to find out more about how these technologies could help your organisation.
Fibrotix: reduced scar area, fibrosis, and hyperpigmentation
Wound healing is complex: excessive inflammation, angiogenesis and dermal fibroblast function significantly contribute to scarring; additionally, scar hyperpigmentation negatively impacts scar quality. We have developed a method of significantly reducing skin scar area, fibrosis and hyperpigmentation, and improving appearance.
To find out more download our Fibrotix PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 229 7487
Optimising embryo implantation during IVF
Advanced reproductive techniques such as IVF and embryo transfer have only 10-25% success rates. We have developed a method of identifying the optimal time for implantation with greater precision than previous techniques, allowing a greater chance of a successful pregnancy.
To find out more download our optimising embryo implantation PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 252 3367
Model of Chronic Pulmonary Infection
Animal models of lung infection with S. pneumoniae are either acute in nature with animals developing bacteraemia and having to be culled within a few days of infection or the nasopharynx (upper airways) only is colonised for a period of time, with no outward signs of disease. We have developed a robust murine model with a persistent S. pneumoniae infection of lungs.
To find out more download our model of chronic pulmonary infection PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 223 1347
MegaPlex PCR
Simple Massively Multiplexed PCR, designed for low cost and automation.
To find out more download our MegaPlex PCR PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 223 1347
Assay for detecting inflammatory molecules in foodstuffs
There is a strong link between Western-style dietary patterns and the development of diabetes and heart disease. Studies show that inflammation plays a central role in the onset of these diseases and that immune-stimulatory molecules, such as pathogen-associated molecular patterns (PAMPs), are involved in the process. We have developed a novel in vitro assay for the detection and quantification of PAMPs in foodstuffs that has applications in both quality control and in the development of new low-PAMP foods.
To find out more download our production of healthier food PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 223 1347
Active Human NEK8 Protein Fragment: Production, purification and optimised activity assay
Kinases are an important class of enzyme which are frequently screened as part of a drug discovery programme. Serine/threonine-protein kinase NEK8 is an enzyme which is thought to play an important role in cell cycle progression from G2 to M phase. Mutations in the NEK8 gene have also been associated with human cystic kidney disease.
We have developed a new protocol for preparing and purifying recombinant NEK8 kinase domain, using readily available reagents. We have also developed and optimised a specific NEK8 kinase assay that could be used alongside other assays in kinase screening or profiling studies.
To find out more download our Active Human NEK8 Protein Fragment Assay PDF or contact:
red-commercial@leicester.ac.uk
+44 (0)116 223 1347